Two HSCI researchers will receive the National Institutes of Health (NIH) Director's New Innovator Award. Jason Buenrostro, Ph.D. and Ryuji Morizane, M.D., Ph.D. have been recognized for their highly innovative biomedical research that has transformative potential.

“Each year, I look forward to seeing the creative approaches these researchers take to solve tough problems in biomedical and behavioral research,” said NIH Director Francis S. Collins in the award...

Improved single-cell ATAC-seq method scales up research into how genes are controlled

Clifford Woolf wants to reboot drug discovery to find a new way to treat pain: effectively and responsibly.

• Woolf’s goal is to stop the opioid crisis by rejecting the conventional approach to drug discovery and developing painkillers that do not harm people or communities. 
• He is using stem cells to create models of pain, outside the body and in a dish, that can be used to screen for drugs swiftly and on a large scale.
• The new approach requires ‘all hands’: expertise, equipment, and collaboration in stem...

Chad Cowan is on a quest for the universal donor, which would make cell therapy available to populations – not just individuals.

• Harvard scientist Chad Cowan aims to make off-the-shelf cellular products, and democratize access to new medicines.
• His lab is working to make cellular therapies that can work for anyone, not just a single patient. 
• Their ambitious goal is to modify therapeutic cells that can be transplanted into many people, without being rejected.

...